AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 21,300
+1,100 (5.45%)
At close: Oct 1, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 585.95 billion as of October 1, 2026. Its market cap has decreased by -15.97% in one year.
Market Cap
585.95B
Enterprise Value
505.75B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
21,300.00
ChartMarket Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 585.95B, an increase of 155.04%. That is a compound annual growth rate of 25.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 585.95B | -54.01% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JS Link | 1.11T |
| Qurient | 916.98B |
| Rznomics | 705.05B |
| ROKIT Healthcare | 507.91B |
| Curocell | 328.91B |
| Inventage Lab | 318.05B |
| IMBiologics | 262.16B |
| IntoCell | 256.88B |